National
Yogi Berra lends name to sports equality movement
Straight allies partnering with LGBT groups to combat discrimination

Legendary Yankees catcher Yogi Berra is an Athlete Ally ambassador. (Photo by Martyna Borkowski; courtesy Wikimedia Commons)
In a little-noticed development, famed New York Yankees catcher Yogi Berra agreed last year to become a ceremonial ambassador for Athlete Ally, an organization that partners with big name sports figures to advocate for full acceptance of LGBT athletes in professional sports.
In addition to allowing Athlete Ally to use his name in promoting LGBT equality, the nationally acclaimed baseball Hall of Famer embraced a proposal to include an LGBT exhibit in the Yogi Berra Museum and Learning Center located on the campus of Montclair State University in New Jersey.
“Yogi is a wonderful example making good choices,” said David Kaplan, executive director of the Berra Museum. “All of our programs and exhibits are about fairness and respect. And our involvement with Athlete Ally and shedding some light on this cause was just so consistent with our mission,” he said.
Berra declined an interview request, due to health issues.
Athlete Ally is among at least a dozen organizations that have either sprung up or expanded their mission in the past several years to take on the cause of LGBT athletes in American sports, both on the professional level and on the high school and college level.
Sam Marchiano, Athlete Ally’s outreach director, said Berra is one of 100 professional athlete ambassadors the group has lined up to advocate on behalf of LGBT equality. She said another 100 college athlete ambassadors have been recruited.
Photos of many of them, including Berra, are prominently featured on the group’s website along with the text of a pledge that Athlete Ally asks all of its allies to sign.
“I pledge to lead my athletic community to respect and welcome all persons, regardless of their perceived or actual sexual orientation, gender identity or gender expression,” the pledge says. “Beginning right now, I will do my part to promote the best of athletics by making all players feel respected on and off the field,” it says.
Cyd Zeigler, co-founder and editor of Out Sports, an online publication that reports on LGBT people in sports, said Athlete Ally is the only organization that currently operates exclusively as a straight ally group.
He noted that all the others, including longtime existing groups like Gay and Lesbian Alliance Against Defamation (GLAAD) and the National Center for Lesbian Rights, have sports-related programs that work with straight allies but are focused mostly on LGBT athletes.
According to Zeigler, the growing number of professional athletes that have come out as gay or lesbian in recent years has begun to change the focus of what he calls the LGBT sports movement from supportive allies to LGBT athletes themselves.
“I come from the perspective that straight allies are fading very quickly into the distance of this movement because there are so many LGBT athletes and LGBT people who are joining the sports movement that straight allies just aren’t needed anymore,” he said.
David McFarland, executive director of United for Equality in Sports and Entertainment, and Wade Davis, executive director of You Can Play Project, two recently formed groups that advocate for LGBT athletes, each agree that the growing number of LGBT athletes coming out publicly is an encouraging development.
But the two also said the number of LGBT athletes coming out is far less than what it should be and that most LGBT athletes on the high school, college and professional level remain reluctant to self-identify as LGBT.
“While many of the most powerful sports institutions have made great strides to publicly support and embrace LGBT equality such as the National Football League, the National Basketball Association, Major League Baseball, the National Hockey League, etc., the truth is that sexual orientation and gender identity remain problematic for many of these organizations within sports at all levels,” McFarland said.
“That’s the reality,” he said. “If this were not the case we would see hundreds if not thousands of LGBT athletes on the playing fields,” said McFarland. “And we would see many more coaches and sports administrators that felt safe enough to come out without the risk of losing their jobs.”
Davis is gay and a former NFL player who, among other teams, played for the Washington Redskins. He said he knows of a number of professional athletes in several different sports that are out to their teammates but are not out publicly.
Davis and McFarland said their respective groups either currently provide or plan to provide educational resources, including training sessions, for players and coaches to dispel myths about LGBT people and lessen the fears and underlying feelings that make it hard for LGBT athletes to come out.
Another of the newer generation of advocacy groups for LGBT athletes is ‘Go! Athletes,’ which consists of a nationwide network of mostly LGBT student athletes and their straight allies. With members in cities throughout the country, the group, which was founded in 2008, has been “spreading the word about LGBT athletes and our experiences with coming out, receiving support, fighting homophobia, transphobia, racism, sexism, and other anti-LGBT discrimination in the world of athletics,” a statement on the group’s website says.
The website says Georgetown University student Craig Casey Jr., who’s gay and was elected as an Advisory Neighborhood Commission member, serves as a Go! Athletes Collegiate Ambassador for Washington, D.C.
The group Br{ache the Silence also works with LGBT student athletes in its mission to “shift the focus from homophobia to inclusion,” it says on its website, freedomsounds.org.
“Br{ache the Silence (BST) advances LGBTQ inclusion in sports through professional college campus integration initiatives and public awareness campaigns,” a message on the website says.
The New York-based Gay, Lesbian & Straight Education Network (GLSEN) advocates for LGBT youth in school sports programs beginning in grades K through 12 through its Changing the Game Project. Among other things, the project works with gym teachers and school athletic programs to curtail and eliminate anti-LGBT bias targeting students.
“What you see at the pro level really starts in kindergarten and on the playground in recess time,” GLSEN official Robert McGarry told the Blade in a past interview. “We’ve been doing training across the country with mostly high school coaches and physical education teachers who seem very receptive and anxious to have this kind of training because it’s not something they get in their preparation and they don’t know what to do.”
GLAAD spokesperson Rich Ferraro said GLAAD for several years now has worked closely with major league sports organizations to persuade them to adopt internal non-discrimination polices protecting LGBT athletes. Virtually all of them have done so, including Major League Baseball, the National Football League, the National Basketball Association and the National Hockey League.
Ferraro said the GLAAD sports project has also lobbied professional sports leagues and teams to make public statements endorsing LGBT equality and condemning anti-LGBT bullying. In response to efforts by GLAAD and other groups, the New York Yankees recently adopted a strict policy prohibiting homophobic taunts and chants by fans at Yankee Stadium during games that calls for ejecting those who violate the policy, Ferraro said.
In its Athletes for Equality program, the Human Rights Campaign Foundation draws attention to LGBT rights by arranging for runners, both LGBT and straight, to participate in marathon races to raise money for the HRC Foundation, according to foundation official Jay Brown.
Brown said HRC sponsored a marathon and half marathon in Akron, Ohio, earlier this month as part of the Gay Games. He said Athletes for Equality will be participating in October in the annual Marine Corps Marathon in D.C.
Zeigler said another recent addition to the LGBT sports advocacy scene was the creation in 2012 by leaders of these and other groups of the LGBT Sports Coalition, which serves as an association of organizations and individuals working to end anti-LGBT bias in sports by 2016.
Last October, Nike Corporation, which bills itself as the world’s largest sports company, donated $200,000 to the LGBT Sports Coalition, expressing strong support for the coalition’s efforts to end bias and discrimination in sports.
Following is a partial list of LGBT athlete advocacy groups.
Athlete Ally
Changing the Game Project
You Can Play Project
United for Equality in Sports and Entertainment
Outsports
GLAAD Sports Project
Go! Athletes
Br{ache the Silence
Homophobia in Sports Project
LGBT Sports Coalition
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
